Advancing DMT into a Phase 1 Clinical Trial

Advancing DMT into a Phase 1 Clinical Trial

Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

October 28, 2022

Latest

First Nordic Metals: Unlocking Gold Opportunities in Sweden and Finland Metals & Mining

Mayfair Gold: Fast-Tracking Gold Production in a High-Opportunity Market Metals & Mining

CEO Clips - White Gold Corp.: Unlocking New Gold Discoveries in the Yukon Metals & Mining

Hot Companies

Aston Bay Holdings